Forecast: Current Health Expenditure in Malaysia

In 2023, Malaysia's current health expenditure stood at $1.26 thousand US dollars PPP per capita. Forecasted data indicates a consistent upward trend: $1.3 in 2024, $1.34 in 2025, $1.38 in 2026, $1.42 in 2027, and $1.47 in 2028.

Year-on-year variations:

  • 2023-2024: 3.17%
  • 2024-2025: 3.08%
  • 2025-2026: 2.99%
  • 2026-2027: 2.90%
  • 2027-2028: 3.52%

The compounded annual growth rate (CAGR) over the last five years is approximately 3.13%. This indicates a stable and continuous increase in health spending per capita.

Future trends to watch for:

  • Policy changes impacting healthcare funding and expenditures.
  • Economic factors influencing the overall spending capacity.
  • Technological advancements expanding healthcare services and efficiencies.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease